
Imatinib Tablets By Ambica Pharma
Price: 2100.00 INR / Bottle
(2100.00 + 0% GST)
Get Latest Price
1 Pack Contains :
1
Minimum Pack Size :
10000
In Stock
Product Specifications
| Salt Composition | Imatinib Mesylate |
| Dosage Form | Tablet |
| Indication | Chronic Myeloid Leukemia, Gastrointestinal Stromal Tumors, Ph+ Acute Lymphoblastic Leukemia, Dermatofibrosarcoma Protuberans |
| Ingredients | Imatinib Mesylate and excipients |
| Application | Oncology, Anticancer Therapy |
| Physical Color/Texture | Yellow to brownish-orange, film-coated tablet |
| Fermentation Smell | Odorless |
| Storage Instructions | Store below 30A C in a dry place, protect from light and moisture |
| Shelf Life | 24 months |
| Feature | Oral therapy for specific cancers, precise dosing, improved quality of life in cancer patients |
| Delivery Time | 01 Week |
| FOB Port | MUMBAI |
| Main Domestic Market | All India |
| Sample Policy | Free samples available with shipping and taxes paid by the buyer |
| Packaging Details | 10X10TAB |
| Main Export Market(s) | Africa |
| Sample Available | 1 |
| Payment Terms | Cheque |
| Supply Ability | 10000 Per Day |
| Certifications | WHO-GMP |
| Unit | 10000 |
| Unit Type | Piece/Pieces |
| Moq | 10000 |
| Price | 2100.00 |
| Selling Price | 2100.00 |
| Brand Name | Imaford |
| Currency | INR |
| Packsize | 1 |
| Mop | 10000 |
| Is Freight Charges | true |
| GSTIN | 0% |
Company Details
This is to introduce ourselves as a professionally managed fast growing Pharmaceutical Company having more than Five Years of Manufacturing and Marketing experience. We are based at Mumbai in the State of Maharashtra. The Company has been accredited with ISO-9001:2008 and manufactures pharmaceutical formulations as per the guidelines of WHO. It is a (GMP Certified) Unit with total quality management and In-house Testing Laboratory. Our success is the result of focusing on our clients top priorities such as quality products, on-time delivery, competitive rates and unparalleled responsiveness. Johnlee manufactures more than 400 plus Pharmaceutical Formulation Products in the form of Tablets, Capsules, Dry syrup, Liquid Orals and Sustained Release Preparations. It is the Company constant and Company will also increasingly focus in high growth potential segments like Vaccines and Biogenetics. These new areas will add significant depth to the existing product pipeline. The proteasome has been validated as an important clinical target in cancer, and Johnlee Pharmaceuticals Pvt. Ltd. is developing next-generation proteasome inhibitors with a high degree of selectivity, with the goal of increasing therapeutic efficacy and reducing side effects.
Business Type
Exporter, Manufacturer, Supplier
Employee Count
20
Establishment
2005
Working Days
To
GST NO
27AGKPJ8183H1ZY
Payment Mode
Cash Advance (CA)
Related Products
Explore Related Categories
More Products From This Seller
Seller Details
GST - 27AGKPJ8183H1ZY
Mumbai, Maharashtra
Director
Mr Vikram K Jain
Address
Office No.22 to 25, 2nd Floor, 72/78, Chapsey Building, Ladwadi, Shamaldas Gandhi Marg, Princess Street, Mumbai, Maharashtra, 400002, India
imatinib drug in Mumbai
Report incorrect details






























